Data is not available at this time.
Wuhan Zhongyuan Huadian Science & Technology operates as a specialized technology provider within China's critical infrastructure sectors, primarily focusing on smart grid solutions and healthcare technology. The company's core revenue model derives from the research, development, manufacturing, and servicing of sophisticated equipment for power system monitoring and automation. Its product portfolio encompasses power fault recording devices, time synchronization systems, substation automation solutions, and intelligent distribution network equipment, serving utilities and grid operators. In the healthcare segment, the company has diversified into medical informatization and in-vitro diagnostic products, creating a dual-engine growth strategy. Positioned as a niche player in China's industrial machinery sector, Zhongyuan Huadian leverages its technical expertise to address the modernization needs of the country's power infrastructure while simultaneously capitalizing on healthcare digitalization trends. The company's market position reflects its deep specialization in high-precision measurement and control technologies, serving both state-owned grid operators and healthcare institutions. This dual-sector approach provides some diversification while maintaining a focus on technology-intensive B2B markets with high barriers to entry.
The company generated CNY 553.7 million in revenue for the period, demonstrating moderate scale within its specialized market segment. Profitability appears solid with net income of CNY 76.97 million, translating to a net margin of approximately 13.9%. Operating cash flow of CNY 120.7 million significantly exceeded net income, indicating strong cash conversion efficiency. The minimal capital expenditures of CNY 3.87 million suggest a capital-light business model with limited ongoing investment requirements for maintaining operations.
Diluted earnings per share stood at CNY 0.16, reflecting the company's earnings capacity relative to its shareholder base. The substantial operating cash flow generation relative to net income underscores efficient working capital management and strong underlying business economics. The company demonstrates adequate earnings power within its niche markets, though absolute earnings levels remain modest given the company's market capitalization and operational scale in the competitive Chinese industrial technology landscape.
Zhongyuan Huadian maintains an exceptionally strong balance sheet with CNY 123.7 million in cash and equivalents against minimal total debt of just CNY 0.1 million. This virtually debt-free position provides significant financial flexibility and resilience. The substantial cash position relative to the company's operational scale indicates conservative financial management and potential capacity for strategic investments or shareholder returns, though it may also suggest limited reinvestment opportunities in its core markets.
The company has established a shareholder return policy, distributing CNY 0.07 per share in dividends during the period. This represents a payout ratio of approximately 44% based on diluted EPS, indicating a balanced approach between retaining earnings for growth and rewarding shareholders. The dividend yield and growth trajectory would require historical context for proper assessment, as current period data alone provides limited insight into the company's long-term growth patterns and capital allocation strategy.
With a market capitalization of approximately CNY 4.0 billion, the company trades at a price-to-earnings ratio of around 52 based on current period earnings. This elevated multiple suggests market expectations for future growth or potential premium assigned to the company's specialized technology portfolio and balance sheet strength. The low beta of 0.118 indicates relatively low correlation with broader market movements, characteristic of niche industrial technology companies with specific demand drivers.
The company's strategic position hinges on its dual-sector focus and specialized technological capabilities in precision measurement and automation. Its virtually debt-free balance sheet provides strategic optionality for potential expansion or weathering industry cycles. The outlook depends on continued investment in China's grid modernization and healthcare digitization initiatives, though competitive pressures and technological evolution present ongoing challenges. The company's niche expertise and financial conservatism position it to capitalize on targeted growth opportunities within its core markets.
Company financial statementsShenzhen Stock Exchange disclosures
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |